Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Modafinil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 known ✓ | Q01959 | 3/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | DRD3 | P35462 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | EDNRB | P24530 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | MC4R | P32245 | 1/20 | 0.43 |
| ▸ | MC3R | P41968 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (S)-Modafinil SCHEMBL1403524 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL34488 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL1560974 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Armodafinil SCHEMBL34489 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL3908867 | 0.96 | EPHX1 (0.42) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL19025521 | 0.95 | PKM (0.41) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL193837 | 0.95 | CYP2D6 (0.41) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL3914634 | 0.95 | PKM (0.41) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL3921259 | 0.95 | PKM (0.41) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 | |
| Modafinil SCHEMBL4957995 | 0.93 | CYP1A2 (0.40) | CYP2D6CYP1A2PKMSMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3675838-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | Puretecch LYT, Inc. (US) | 2020-07-08 | — | — | EP | disclosed |
| WO-2019046491-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | ARIYA THERAPEUTICS, INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| WO-2010014887-A1 | METHOD AND APPARATUS FOR IDENTIFYING A SAFE AND EFFICACIOUS DOSING REGIMEN | THE MCLEAN HOSPITAL CORPORATION (US) | 2010-02-04 | — | — | WO | disclosed |
| US-7553646-B2 | Microbial sulfoxidation and amidation of benzhdrylsulfanyl carboxylic acids and uses thereof | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2009-06-30 | — | — | US | disclosed |
| WO-2007027328-A2 | MICROBIAL SULFOXIDATION AND AMIDATION OF BENZHDRYLSULFANYL CARBOXYLIC ACIDS AND USES THEREOF | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2007-03-08 | — | — | WO | disclosed |
| US-20070026507-A1 | MICROBIAL SULFOXIDATION AND AMIDATION OF BENZHDRYLSULFANYL CARBOXYLIC ACIDS AND USES THEREOF | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2007-02-01 | — | — | US | disclosed |
| EP-1670447-A1 | MODAFINIL MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS | CEPHALON, INC. (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1633338-A1 | COMBINATION OF THE ANALEPTIC MODAFINIL AND AN ANTIDEPRESSANT FOR THE TREATMENT OF DEPRESSION | CEPHALON, INC. (US) | 2006-03-15 | — | — | EP | disclosed |
| WO-2005112911-A2 | COMPOSITIONS AND METHODS FOR TREATING MYELIN DEFICIENCY DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-01 | — | — | WO | disclosed |
| WO-2005063248-A1 | MODAFINIL COMBINATION THERAPY FOR IMPROVING SLEEP QUALITY | SEPRACOR INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| WO-2005027890-A1 | MODAFINIL MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS | CEPHALON, INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| WO-2004100939-A1 | COMBINATION OF THE ANALEPTIC MODAFINIL AND AN ANTIDEPRESSANT FOR THE TREATMENT OF DEPRESSION | CEPHALON, INC. (US) | 2004-11-25 | — | — | WO | disclosed |